Join the frontline of biologic therapies
This three-day congress program on orthobiologics and biological therapies is structured to provide an in-depth look at how biological therapies are revolutionizing the treatment of joint and sports pathologies. Here is a more detailed summary of the topics that will be addressed.
Joint Degeneration
Addressing the use of orthobiology in the treatment of joint degeneration, with the aim of understanding the processes that lead to joint degeneration and how biological therapies can be a powerful therapeutic tool in this type of pathology.
· Orthobiology and pathophysiology of osteoarthritis
An update on current orthobiological products, such as platelet-rich plasma (PRP) and stem cells, as well as an in-depth look at the cellular processes that lead to joint degeneration. This block will be key to understanding how orthobiology acts on this condition.
· Application of orthobiological treatments
Different biological products and their application techniques for the treatment of joint degeneration will be explored.
· Controversies and consensus
Review of the different controversies that exist in orthobiology and how, through consensus, recommendations for use based on scientific evidence are beginning to be established.
Pain and Sports Medicine
The application of orthobiology in both pain medicine and sports medicine, covering a wide range of pathologies.
· Pain Medicine
o Peripheral Nerve: exploration of peripheral nerve injuries from a biological, multidisciplinary perspective by orthopaedic surgeons and pain physicians.
o Spine: use of biological therapies for the treatment of spine pathologies, addressing the different structures and tissues.
· Sports medicine
o Ligament and muscle: analysis of orthobiologic applications in ligament and muscle injuries.
o Tendon and meniscus: the treatment of tendon and meniscal injuries will be discussed as well as the use of orthobiologics in professional sports.
Horizons in Cell Biology and Regenerative Therapies
Addressing key topics in biologic therapies that may mark the future of orthobiologics, such as inflammatory processes and their impact, the emerging role of bioprinting, pediatric application, regulatory challenges facing new therapies and how to better involve the patient in the decision-making process, considering their expectations and long-term outcomes.
In addition, complementary activities, such as Breakfast rounds and Expert battles, will further enrich the program. These sessions will provide valuable additional information, encourage the exchange of innovative ideas and allow attendees to delve deeper into specific topics in a dynamic and participatory way.
Overall, the congress offers a space for updating, debate and consensus building in a discipline that aims to improve the quality of life and functional recovery of patients through advanced biological therapies.